Effects of blood glucose level on 18F fluorodeoxyglucose (18F-FDG) uptake for PET/CT in normal organs: an analysis on 5623 patients
Open accessThe DOI matches its Crossref record; 25 of the 26 references it cites were found in a registry or an index.
Abstract
Our purpose was to evaluate the effect of glycemia on 18 F-FDG uptake in normal organs of interest. The influences of other confounding factors, such as body mass index (BMI), diabetes, age, and sex, on the relationships between glycemia and organ-specific standardized uptake values (SUVs) were also investigated. We retrospectively identified 5623 consecutive patients who had undergone clinical PET/CT for oncological indications. Patients were stratified into groups based on glucose levels, measured immediately before 18 F-FDG injection. Differences in mean SUVmax values among glycemic ranges were clinically significant only when >10% variation was observed. The brain was the only organ that presented a significant inverse relationship between SUVmax and glycemia (p < 0.001), even after controlling for diabetic status. No such difference was observed for the liver or lung. After adjustment for sex, age, and BMI, the association of glycemia with SUVmax was significant for the brain and liver, but not for the lung. In conclusion, the brain was the only organ analyzed showing a clinically significant relationship to glycemia after adjustment for potentially confounding variables. The lung was least affected by the variables in our model, and may serve as an alternative background tissue to the liver.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“On multivariate analysis, there was an inconsistent association with the confounding factors on either occasion and blood glucose level did not have a significant effect on their SUVmax as concordant with previous studies.[1,3]”
From Intrapatient variability of 18F-FDG uptake in normal tissues (2022) · cites this paper as [3]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Several studies suggested that the blood pool is a more optimal and stable reference tissue than the liver,[1,3,25,39,41] as it is much less dependent than the liver on glycemia and other variables.[10]”
From Intrapatient variability of 18F-FDG uptake in normal tissues (2022) · cites this paper as [3]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This suggests effects on SUV in obese patients that are specific for [18F]FDG, possibly stemming from the positive correlation between BMI and blood glucose [3,6].”
From Influences on PET Quantification and Interpretation (2022) · cites this paper as [3]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In a number of normal organs, the SUV corrected for body mass is positively correlated with the body mass index (BMI) [1,2,3].”
From Influences on PET Quantification and Interpretation (2022) · cites this paper as [3]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
Wahl, R. L., Jacene, H., Kasamon, Y., & Lodge, M. A. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.057307 · Cited by 3,777
FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0
Boellaard, R., Delgado-Bolton, R., Oyen, W. J. G., Giammarile, F., Tatsch, K., Eschner, W., Verzijlbergen, F. J., Barrington, S. F., Pike, L. C., Weber, W. A., et al. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-014-2961-x · Cited by 3,303
Procedure guideline for tumor imaging with 18F-FDG PET/CT 1.0.
Delbeke, D., Coleman, R. E., Guiberteau, M. J., Brown, M. L., Royal, H. D., Siegel, B. A., Townsend, D. W., Berland, L. L., Parker, J. A., Hubner, K., et al. (2006) · PubMed · Cited by 689
Progress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug Development
Kelloff, G. J., Hoffman, J. M., Johnson, B., Scher, H. I., Siegel, B. A., Cheng, E. Y., Cheson, B. D., O'Shaughnessy, J., Guyton, K. Z., Mankoff, D. A., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2626 · Cited by 671
Zasadny, K. R., & Wahl, R. L. (1993) · Radiology · doi:10.1148/radiology.189.3.8234714 · Cited by 635
Kinahan, P. E., & Fletcher, J. W. (2010) · Seminars in Ultrasound, CT and MRI · doi:10.1053/j.sult.2010.10.001 · Cited by 631
Procedure guideline for tumor imaging with F-18 FDG PET/CT
Delbeke, D., Coleman, R. E., Guiberteau, M. J., Brown, M. L., Royal, H. D., Siegel, B. A., Townsend, D. W., Berland, L. L., Parker, J. A., Hübner, K. F., et al. (2006) · Cited by 620
Huang, (. S.-C. (2000) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(00)00155-4 · Cited by 458
Reproducibility of metabolic measurements in malignant tumors using FDG PET.
Weber, W., Ziegler, S. I., Thödtmann, R., Hanauske, A.-R., & Schwaiger, M. (1999) · PubMed · Cited by 388
Minn, H., Zasadny, K. R., Quint, L. E., & Wahl, R. L. (1995) · Radiology · doi:10.1148/radiology.196.1.7784562 · Cited by 260
Cited by
Ge, J., Zhang, Q., Zeng, J., Gu, Z., & Gao, M. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2019.119553 · Cited by 180
Strategies for the Development of Glycomimetic Drug Candidates
Hevey, R. (2019) · Pharmaceuticals · doi:10.3390/ph12020055 · Cited by 138
“This widespread recognition of fluorinated glyco-analogues has been a contributing factor to the success of 18F-2-deoxy-2-fluoro-d-glucose (8) as a radiotracer for diagnosing neoplasia through positron emission tomography (PET scans) [47,48].”
BackgroundEskian, M., Alavi, A., Khorasanizadeh, M., Viglianti, B. L., Jacobsson, H., Barwick, T. D., Meysamie, A., Yi, S. K., Iwano, S., Bybel, B., et al. (2019) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-018-4194-x · Cited by 109
Intensity normalization methods in brain FDG-PET quantification
López‐González, F. J., Silva‐Rodríguez, J., Paredes‐Pacheco, J., Niñerola‐Baizán, A., Efthimiou, N., Martín‐Martín, C., Moscoso, A., Ruibal, Á., Roé-Vellvé, N., & Aguiar, P. (2020) · NeuroImage · doi:10.1016/j.neuroimage.2020.117229 · Cited by 82
Assessing PET Parameters in Oncologic 18F-FDG Studies
Sarikaya, İ., & Sarıkaya, A. (2019) · Journal of Nuclear Medicine Technology · doi:10.2967/jnmt.119.236109 · Cited by 64
“Per our recent assessment, hyperglycemia does not affect liver and blood-pool activity (12,40,41).”
Background
Metadata
- Authors
- Sprinz, C., Zanon, M., Altmayer, S., Watte, G., Irion, K., Marchiori, E., & Hochhegger, B.
- Affiliations
- Hospital Mãe de Deus (BR)
- Universidade Federal de Ciências da Saúde de Porto Alegre (BR)
- Manchester Royal Infirmary (GB)
- Universidade Federal do Rio de Janeiro (BR)
- Corresponding author
- Zanon, Matheus
- Venue
- Scientific Reports
- Published
- 2018-02-01
- Volume
- 8
- Issue
- 1
- Pages
- 2126-2126
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC5794870
- OpenAlex
- W2802218762
- Cited by
- 59
- References
- 26
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 12 · 2023: 10 · 2022: 3 · 2021: 2 · 2020: 10 · 2019: 12 · 2018: 1
- FWCI
- 4.31
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (publishedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Lung Cancer Diagnosis and Treatment
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiopharmaceutical Chemistry and Applications
- Keywords
- FDG uptake, blood glucose, glycemia, standardized uptake value, SUVmax, PET/CT, brain, liver, lung, body mass index, diabetes mellitus, confounding factors
- MeSH terms
- Positron Emission Tomography Computed Tomography, Aged, Blood Glucose, Brain, Female, Humans, Liver, Lung, Male, Middle Aged, Retrospective Studies, Radiopharmaceuticals, Fluorodeoxyglucose F18
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effects of blood glucose level on 18F fluorodeoxyglucose (18F-FDG) uptake for PET/CT in normal organs: an analysis on 5623 patients. https://app.cochat.ai/papers/10.1038/s41598-018-20529-4
- The paper
- Sprinz, C., Zanon, M., Altmayer, S., Watte, G., Irion, K., Marchiori, E., & Hochhegger, B. (2018). Effects of blood glucose level on 18F fluorodeoxyglucose (18F-FDG) uptake for PET/CT in normal organs: an analysis on 5623 patients. Scientific Reports. https://doi.org/10.1038/s41598-018-20529-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.